you are here:

Abbott India Ltd.

BSE: 500488 | NSE: ABBOTINDIA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE358A01014 | SECTOR: Pharmaceuticals

BSE Live

Jan 19, 16:00
14618.95 -138.90 (-0.94%)
Volume
AVERAGE VOLUME
5-Day
2,560
10-Day
2,475
30-Day
1,619
3,350
  • Prev. Close

    14757.85

  • Open Price

    14890.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 19, 15:58
14601.70 -146.95 (-1.00%)
Volume
AVERAGE VOLUME
5-Day
25,798
10-Day
23,252
30-Day
21,793
27,878
  • Prev. Close

    14748.65

  • Open Price

    14844.65

  • Bid Price (Qty.)

    14601.70 (19)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Abbott India

  • Jan 15, 2021 10:28 Source: BSE

    Abbott India - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation under Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Jan 11, 2021 16:36 Source: BSE

    Abbott India - Shareholding for the Period Ended December 31, 2020

    Abbott India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here

  • Jan 04, 2021 15:39 Source: BSE

    Abbott India - Statement Of Investor Complaints For The Quarter Ended December 2020

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0440
    Name of the Signatory :- Krupa Anandpara
    Designation :- Company Secretary and Compliance Officer

  • Jan 04, 2021 15:33 Source: BSE

    Abbott India - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed, Certificate issued by KFin Technologies Private Limited, Registrar and Share Agent of the Company for the third quarter ended December 31, 2020. Kindly acknowledge receipt of the same.

  • Dec 30, 2020 9:48 Source: BSE

    Abbott India - Closure of Trading Window

    This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the shares of the Company by the Designated Persons and their immediate relatives shall be closed from tomorrow i.e. Thursday, December 31, 2020 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the third quarter ended on December 31, 2020. You are requested to take the same on record.

  • Nov 30, 2020 17:13 Source: BSE

    Abbott India - Disclosure Under Regulation 23(9) Of The SEBI (LODR) 2015

    Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2020. The above disclosure is also available on the website of the Company i.e. www.abbott.co.in This is for your information and record.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Nov 11, 2020
Remark : Quarterly Results